Selrence Medical Gases Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.60 M
- Revenue Growth 14.08%
- Profit Growth 4.27%
- Ebitda 16.83%
- Net Worth 13.90%
- Total Assets -4.14%
About Selrence Medical Gases
Selrence Medical Gases Private Limited (SMGPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 June 1998 and has a history of 26 years and seven months. Its registered office is in Thiruvananthapuram, Kerala, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.60 M.
Mathew Lawrence, Sujita Pereira, and Sumita Rozario serve as directors at the Company.
Company Details
-
Location
Thiruvananthapuram, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24111KL1998PTC012352
-
Company No.
012352
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Jun 1998
-
Date of AGM
29 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Selrence Medical Gases?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mathew Lawrence | Managing Director | 26-Jun-1998 | Current |
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sujita Pereira | Director | 01-Dec-2000 | Current |
Sumita Rozario | Director | 01-Dec-2000 | Current |
Financial Performance of Selrence Medical Gases.
Selrence Medical Gases Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 14.08% increase. The company also saw a slight improvement in profitability, with a 4.27% increase in profit. The company's net worth Soared by an impressive increase of 13.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Selrence Medical Gases?
In 2019, Selrence Medical Gases had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.60 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.11 Cr
- Sundaram Finance Ltd : 0.06 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
21 Aug 2006 | Sundaram Finance Ltd | ₹0.55 M | Open |
04 Jan 2005 | State Bank Of India | ₹1.05 M | Open |
How Many Employees Work at Selrence Medical Gases?
Unlock and access historical data on people associated with Selrence Medical Gases, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Selrence Medical Gases, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Selrence Medical Gases's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.